Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Opposing effects of IL-1 alpha and IL-1 beta on malignancy patterns. Tumor cell-associated IL-1 alpha potentiates anti-tumor immune responses and tumor regression, whereas IL-1 beta potentiates invasiveness.

× No keyword cloud information.

6 in total

1. The Interleukin (IL)-1R1 pathway is a critical negative regulator of PyMT-mediated mammary tumorigenesis and pulmonary metastasis.

Authors: Maryse Dagenais; Jeremy Dupaul-Chicoine; Todd Douglas; Claudia Champagne; Alexandre Morizot; Maya Saleh
Journal: Oncoimmunology Date: 2017-02-06 Impact factor: 8.110

2. Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes.

Authors: Mamadou Keita; Paul Bessette; Manuella Pelmus; Youssef Ainmelk; Aziz Aris
Journal: J Ovarian Res Date: 2010-01-28 Impact factor: 4.234

3. Human Prostate Cancer Cells Secrete Neuro-Protective Factors in Response to Cryotherapy.

Authors: Seema Gupta; Mini Varghese; Mohammed M Shareef; Mansoor M Ahmed
Journal: Mol Cell Pharmacol Date: 2009-01-01

4. IL-1 is required for tumor invasiveness and angiogenesis.

Authors: Elena Voronov; Dror S Shouval; Yakov Krelin; Emanuela Cagnano; Daniel Benharroch; Yoichiro Iwakura; Charles A Dinarello; Ron N Apte
Journal: Proc Natl Acad Sci U S A Date: 2003-02-21 Impact factor: 11.205

5. IL-15 deficient tax mice reveal a role for IL-1α in tumor immunity.

Authors: Daniel A Rauch; John C Harding; Lee Ratner
Journal: PLoS One Date: 2014-01-08 Impact factor: 3.240

6. Epidermal growth factor protects squamous cell carcinoma against cisplatin-induced cytotoxicity through increased interleukin-1β expression.

Authors: Shian-Chin Ko; Chi-Ruei Huang; Jiunn-Min Shieh; Jhen-Hong Yang; Wen-Chang Chang; Ben-Kuen Chen
Journal: PLoS One Date: 2013-02-01 Impact factor: 3.240

6 in total